Submission delayed by U.S. government shutdown; initial FDA questions expected during Q4 2025 "The Pivot submission is an exciting milestone in our mission to deliver a differentiated tubeless patch ...
SAN DIEGO, CA / ACCESS Newswire / November 17, 2025 / Modular Medical, Inc. (MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology targeting the $3 billion ...
Modular Medical Announces Successful Validation of Controller Line for Pivot Insulin Delivery System
Pivot Controller Line Validated: Manufacturing line has now been validated for human-use production in support of expected Q1 2026 market launch. Pivot will be First Two-Part Tubeless Patch Pump: ...
"The Pivot submission is an exciting milestone in our mission to deliver a differentiated tubeless patch pump experience to those who want a simple pump to manage the treatment of diabetes," commented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback